Robert M Dewitty

Array ( [id] => 1009137 [patent_doc_number] => 06899897 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-31 [patent_title] => 'Gum resin as a carrier for topical application of pharmacologically active agents' [patent_app_type] => utility [patent_app_number] => 10/053313 [patent_app_country] => US [patent_app_date] => 2002-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6119 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/899/06899897.pdf [firstpage_image] =>[orig_patent_app_number] => 10053313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082471 [patent_doc_number] => 20020082244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Compositions and methods for inhibiting bone resorption' [patent_app_type] => new [patent_app_number] => 10/029678 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8030 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082244.pdf [firstpage_image] =>[orig_patent_app_number] => 10029678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843559 [patent_doc_number] => 20020131992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Method and product for treating cancer in pets' [patent_app_type] => new [patent_app_number] => 10/026006 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6190 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20020131992.pdf [firstpage_image] =>[orig_patent_app_number] => 10026006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6429878 [patent_doc_number] => 20020127287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Treatment of lyso paf-mediated disorders with lyso paf or paf antagonists and procedure for determining their efficacy' [patent_app_type] => new [patent_app_number] => 10/021005 [patent_app_country] => US [patent_app_date] => 2001-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10638 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20020127287.pdf [firstpage_image] =>[orig_patent_app_number] => 10021005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668369 [patent_doc_number] => 20030113352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Neutralization of stratum corneum to treat hyperkeratotic skin lesions' [patent_app_type] => new [patent_app_number] => 10/017841 [patent_app_country] => US [patent_app_date] => 2001-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9889 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113352.pdf [firstpage_image] =>[orig_patent_app_number] => 10017841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1228692 [patent_doc_number] => 06696454 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-24 [patent_title] => 'Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation' [patent_app_type] => B2 [patent_app_number] => 10/023038 [patent_app_country] => US [patent_app_date] => 2001-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 15720 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/696/06696454.pdf [firstpage_image] =>[orig_patent_app_number] => 10023038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1450700 [patent_doc_number] => 06455557 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Method of reducing somnolence in patients treated with tizanidine' [patent_app_type] => B1 [patent_app_number] => 09/994837 [patent_app_country] => US [patent_app_date] => 2001-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6313 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455557.pdf [firstpage_image] =>[orig_patent_app_number] => 09994837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5923382 [patent_doc_number] => 20020115695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Combination therapies for the stimulation of bone growth' [patent_app_type] => new [patent_app_number] => 10/020295 [patent_app_country] => US [patent_app_date] => 2001-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6080 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115695.pdf [firstpage_image] =>[orig_patent_app_number] => 10020295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688852 [patent_doc_number] => 20030032577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Therapeutic uses for nitric oxide inhibitors' [patent_app_type] => new [patent_app_number] => 09/999779 [patent_app_country] => US [patent_app_date] => 2001-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20463 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032577.pdf [firstpage_image] =>[orig_patent_app_number] => 09999779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5922847 [patent_doc_number] => 20020115586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Therapeutic uses for nitric oxide inhibitors' [patent_app_type] => new [patent_app_number] => 10/045204 [patent_app_country] => US [patent_app_date] => 2001-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17209 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115586.pdf [firstpage_image] =>[orig_patent_app_number] => 10045204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5788884 [patent_doc_number] => 20020161054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Use of tolterodine to treat asthma' [patent_app_type] => new [patent_app_number] => 10/045135 [patent_app_country] => US [patent_app_date] => 2001-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1854 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20020161054.pdf [firstpage_image] =>[orig_patent_app_number] => 10045135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1065720 [patent_doc_number] => 06846846 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-25 [patent_title] => 'Gentle-acting skin disinfectants' [patent_app_type] => utility [patent_app_number] => 10/047631 [patent_app_country] => US [patent_app_date] => 2001-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7915 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/846/06846846.pdf [firstpage_image] =>[orig_patent_app_number] => 10047631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1291652 [patent_doc_number] => 06630477 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-07 [patent_title] => 'Therapeutic nucleoside compound' [patent_app_type] => B1 [patent_app_number] => 09/913309 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4602 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630477.pdf [firstpage_image] =>[orig_patent_app_number] => 09913309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1127002 [patent_doc_number] => 06790855 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-14 [patent_title] => 'Topical anesthetic/opioid formulations and uses thereof' [patent_app_type] => B2 [patent_app_number] => 09/975812 [patent_app_country] => US [patent_app_date] => 2001-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8964 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/790/06790855.pdf [firstpage_image] =>[orig_patent_app_number] => 09975812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1242654 [patent_doc_number] => RE038386 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2004-01-13 [patent_title] => 'Retardation of metalloproteinase incidental to HIV and/or AIDS' [patent_app_type] => E1 [patent_app_number] => 09/973331 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4813 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038386.pdf [firstpage_image] =>[orig_patent_app_number] => 09973331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033364 [patent_doc_number] => 20020019351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Treatment of skeletal disorders' [patent_app_type] => new [patent_app_number] => 09/965760 [patent_app_country] => US [patent_app_date] => 2001-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9859 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019351.pdf [firstpage_image] =>[orig_patent_app_number] => 09965760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5874761 [patent_doc_number] => 20020049198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Methods for treating osteoarthritis using an estrogen agonist / antagonist' [patent_app_type] => new [patent_app_number] => 09/956696 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11754 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049198.pdf [firstpage_image] =>[orig_patent_app_number] => 09956696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6623374 [patent_doc_number] => 20020065319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => 'Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid' [patent_app_type] => new [patent_app_number] => 09/956509 [patent_app_country] => US [patent_app_date] => 2001-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1854 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20020065319.pdf [firstpage_image] =>[orig_patent_app_number] => 09956509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1300562 [patent_doc_number] => 06624195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-23 [patent_title] => 'Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid' [patent_app_type] => B2 [patent_app_number] => 09/956739 [patent_app_country] => US [patent_app_date] => 2001-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1858 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/624/06624195.pdf [firstpage_image] =>[orig_patent_app_number] => 09956739 [rel_patent_id] =>[rel_patent_doc_number] =>)